Sonoma Pharmaceuticals (SNOA) Operating Income Growth (3y) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 40.17% |
| 10 | Sonoma Pharmaceuticals | 1.92 Mn | -479,240.02 | 2.18 Mn | 32.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.61% |
| Dec 31, 2025 | 28.23% |
| Sep 30, 2025 | 22.75% |
| Jun 30, 2025 | -8.60% |
| Mar 31, 2025 | 40.15% |
| Dec 31, 2024 | -2.48% |
| Sep 30, 2024 | 4.11% |
| Jun 30, 2024 | -9.07% |
| Mar 31, 2024 | 20.59% |
| Dec 31, 2023 | -82.88% |
| Sep 30, 2023 | -109.14% |
| Jun 30, 2023 | -23.08% |
| Mar 31, 2023 | 29.14% |
| Dec 31, 2022 | -18.29% |
| Sep 30, 2022 | 17.18% |
| Jun 30, 2022 | 21.55% |
| Mar 31, 2022 | -4.21% |
| Dec 31, 2021 | 25.85% |
| Sep 30, 2021 | 28.63% |
| Jun 30, 2021 | 36.63% |